Manufacturing qualified ureteral stents faces multiple material-related hurdles, from continuous tube extrusion stability to anti-encrustation performance after implantation. We communicate daily with medical component manufacturers, and summarised the most frequent pain points clients encounter, along with how our custom medical-grade TPU addresses these challenges.
The first common issue is unstable extrusion performance. Many generic medical polymers cause frequent tube wall thickness deviation, surface defects or die buildup during high-speed continuous production. These defects lead to high rejection rates. Our TPU formula for ureteral stPU undergoes strict viscosity control. It delivers consistent melt flow, supporting smooth thin-wall tubing extrusion for specifications ranging from 4Fr to 8Fr. Clean manufacturing grade raw pellets minimise impurities that cause surface blemishes on finished catheters.
Encrustation remains one of the biggest clinical complaints for ureteral stents. Mineral deposits and bacterial biofilm build up on stent surfaces, blocking drainage and triggering infection. While raw material cannot fully eliminate encrustation, premium TPU creates a smoother base surface. It works perfectly with hydrophilic coating processes adopted by most stent producers. Uniform material properties ensure coatings attach firmly without peeling during long-term implantation. Poor base material often leads to partial coating loss after short indwelling time.
Many material suppliers overlook sterilisation stability. Some TPUs suffer massive elongation loss after gamma radiation, making finished stents brittle. Our ureteral stent TPU is pre-tested under standard medical irradiation dosages. Mechanical property retention meets the expectations of global medical regulators. Manufacturers do not need to adjust processing parameters drastically for post-production sterilisation.
Regulatory compliance creates another challenge for export-oriented factories. All our medical TPU comes with complete batch test reports, supporting clients to compile technical files for CE, FDA and local medical device registration. We avoid unknown additive mixtures; every ingredient inside the polymer is traceable and meets medical contact requirements.
We provide sample testing service for new product development. Device producers can run extrusion trials, simulate in-vivo hydrolysis tests and sterilisation validation before bulk orders. From small-batch prototype development to full-scale mass production, our technical team offers continuous material support. If you are currently searching for reliable raw materials to upgrade your ureteral stent product line, our dedicated medical TPU series is ready for your evaluation. (Word count: 592)